Monoamine oxidase inhibitors (MAOIs)
MAOIs were the first type of antidepressant developed. Learn about the benefits, side effects and risks of these antidepressants.By Mayo Clinic Staff
Monoamine oxidase inhibitors (MAOIs) were the first type of antidepressant developed. They're effective, but they've generally been replaced by antidepressants that are safer and cause fewer side effects.
Use of MAOIs typically requires diet restrictions because they can cause dangerously high blood pressure when taken with certain foods or medications. In spite of side effects, these medications are still a good option for some people. In certain cases, they relieve depression when other treatments have failed.
How MAOIs work
Antidepressants such as MAOIs ease depression by affecting chemical messengers (neurotransmitters) used to communicate between brain cells. Like most antidepressants, MAOIs work by ultimately effecting changes in the brain chemistry that are operational in depression.
An enzyme called monoamine oxidase is involved in removing the neurotransmitters norepinephrine, serotonin and dopamine from the brain. MAOIs prevent this from happening, which makes more of these brain chemicals available to effect changes in both cells and circuits that have been impacted by depression.
MAOIs also affect other neurotransmitters in the brain and digestive system, causing side effects. MAOIs are sometimes used to treat conditions other than depression, such as Parkinson's disease.
MAOIs approved to treat depression
The Food and Drug Administration (FDA) has approved these MAOIs to treat depression:
- Isocarboxazid (Marplan)
- Phenelzine (Nardil)
- Selegiline (Emsam)
- Tranylcypromine (Parnate)
Selegiline is available as a skin (transdermal) patch. Using a patch may cause fewer side effects than MAOIs taken by mouth. If you're using the lowest dose patch, you may not need diet restrictions, but ask your doctor.
Side effects of MAOIs
Because of side effects and safety concerns, MAOIs are most often tried when other antidepressants don't work.
The most common side effects of MAOIs include:
- Dry mouth
- Nausea, diarrhea or constipation
- Dizziness or lightheadedness
- Skin reaction at the patch site
Other possible side effects include:
June 08, 2016
- Involuntary muscle jerks
- Low blood pressure
- Reduced sexual desire or difficulty reaching orgasm
- Weight gain
- Difficulty starting a urine flow
- Muscle cramps
- Prickling or tingling sensation in the skin (paresthesia)
See more In-depth
- Mental health medications. National Institute of Mental Health. http://www.nimh.nih.gov/health/topics/mental-health-medications/index.shtml. Accessed May 16, 2016.
- Hirsch M, et al. Monoamine oxidase inhibitors (MAOIs) for treating depressed adults. http://www.uptodate.com/home. Accessed May 16, 2016.
- Hirsch M, et al. Discontinuing antidepressant medications in adults. http://www.uptodate.com/home. Accessed May 17, 2016.
- Boyer EW. Serotonin syndrome (serotonin toxicity). http://www.uptodate.com/home. Accessed May 17, 2016.
- What is pharmacogenomics? Genetics Home Reference. https://ghr.nlm.nih.gov/primer/genomicresearch/pharmacogenomics. Accessed May 16, 2016.
- Revisions to product labeling. U.S. Food and Drug Administration. http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM173233.pdf. Accessed May 5, 2016.
- Stevens JR, et al. The use of transdermal therapeutic systems in psychiatric care: A primer on patches. Psychosomatics. 2015;56:423.
- Ranga Rama Krishnan K. Monoamine oxidase inhibitors. In: The American Psychiatric Publishing Textbook of Psychopharmacology. 4th ed. Washington, D.C.: American Psychiatric Publishing; 2009. http://psychiatryonline.org. Accessed May 16, 2016.
- Flockhart DA. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: An update. Journal of Clinical Psychiatry. 2012;73(suppl):17.
- Moreland CS, et al. Effect of antidepressants on suicide risk in children and adolescents. http://www.uptodate.com/home. Accessed May 17, 2016.
- Buss Preszler LK (expert opinion). Mayo Clinic, Rochester, Minn. May 27, 2016.
- Hall-Flavin DK (expert opinion). Mayo Clinic, Rochester, Minn. May 28, 2016.